Skip to main content

Table 1 Antibody information

From: Colon adenoma and adenocarcinoma with clear cell components - two case reports

Antibody

Clone

Company

Dilution

Conditioning

CK7

OV-TL 12/30

DAKO, Santa Clara, USA

1:50

Protease

CK20

Ks 20.8

DAKO, Santa Clara, USA

1:50

Protease

CDX2

AMT28

Novus Biologicals, Newcastle, UK

1:50

pH 9.0

CEA

II-7

DAKO, Santa Clara, USA

1:40

pH 6.0

CD10

56C6

Novocastra, Newcastle, UK

1:50

pH 6.0 overnight

MUC2

Ccp58

Novocastra, Newcastle, UK

1:100

pH 6.0

MUC5AC

CLH2

Abcam, Cambridge, UK

1:1000

 

MUC6

CLH5

Novocastra, Newcastle, UK

1:100

pH 6.0

AFP

N1501

DAKO, Santa Clara, USA

diluted

 

Glypican3

1G12

Nichirei Bioscience, Tokyo, Japan

diluted

pH 9.0

AR

AR441

DAKO, Santa Clara, USA

1:25

pH 6.0

Perilipin

GP29

PROGEN, Heidelberg, Germany

1:200

pH 6.0

Adipophilin

AP125

Acris Antibodies, Herford, Germany

1:10

pH 6.0

Ki67

MIB-1

DAKO, Santa Clara, USA

1:50

pH 6.0

COX2

CX-294

DAKO, Santa Clara, USA

1:100

pH 9.0

APC

CC-1

Oncogene, California, USA

1:20

pH 6.0

  1. CK Cytokeratin, CDX2 Caudal type homeobox 2, CEA Carcinoembryonic antigen, CD Cluster differentiation, MUC Mucin, AFP Alpha fetoprotein, AR Androgen receptor, COX2 Cyclooxygenase 2, APC Adenomatous polyposis coli